Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Supporting the health care transition through multidisciplinary collaboration: professional initiatives].

Rinsho shinkeigaku = Clinical neurology·2026
Same author

Biallelic variants in TNR cause neurodevelopmental disorders with variable expressivity.

Journal of human genetics·2025
Same author

Efficacy and Safety of 5-Aminolevulinic Acid Hydrochloride Combined with Sodium Ferrous Citrate in Pediatric Patients with Leigh Syndrome and Central Nervous System Disorders: An Initial Exploratory Trial with a Double-Blind Placebo-Controlled Period, Followed by an Open-Label Period and a Subsequent Long-Term Administration Study.

Life (Basel, Switzerland)·2025
Same author

The Mini-COMET Clinical Trial: Safety and Efficacy of Avalglucosidase Alfa after 97 Weeks of Treatment in Children with Infantile-Onset Pompe Disease Previously Treated with Alglucosidase Alfa.

The Journal of pediatrics·2025
Same author

Deep Brain Stimulation Withdrawal without Relapse in Chorea-Acanthocytosis: Two Case Reports.

Movement disorders clinical practice·2025
Same author

Efficacy and safety of avalglucosidase alfa in Japanese patients with late-onset and infantile-onset Pompe diseases: A case series from clinical trials.

Molecular genetics and metabolism reports·2025

Related Experiment Video

Updated: Jan 26, 2026

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

37.2K

[Ataxia Telangiectasia].

Satoko Kumada1

  • 1Department of Neuropediatrics, Tokyo Metropolitan Neurological Hospital.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|April 17, 2019
PubMed
Summary

Ocular telangiectasias, a key sign of ataxia telangiectasia (AT), typically emerge after age six. Their presence aids AT diagnosis, though they may be absent in milder cases.

Area of Science:

  • Ophthalmology
  • Genetics
  • Neurology

Background:

  • Ocular telangiectasias are characteristic of ataxia telangiectasia (AT).
  • These vascular abnormalities usually manifest after six years of age.
  • Skin and visceral telangiectasias can develop later, potentially indicating progeric changes.

Purpose of the Study:

  • To highlight the diagnostic significance of ocular telangiectasias in Ataxia Telangiectasia.
  • To discuss the typical age of onset for ocular telangiectasias.
  • To explore the variability in presentation, including milder variants.

Main Methods:

  • Clinical observation and diagnosis of patients with Ataxia Telangiectasia.
  • Age-based analysis of telangiectasia manifestation.

More Related Videos

High-throughput Analysis of Locomotor Behavior in the Drosophila Island Assay
10:30

High-throughput Analysis of Locomotor Behavior in the Drosophila Island Assay

Published on: November 5, 2017

9.2K
Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration
08:41

Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration

Published on: December 27, 2024

2.0K

Related Experiment Videos

Last Updated: Jan 26, 2026

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

37.2K
High-throughput Analysis of Locomotor Behavior in the Drosophila Island Assay
10:30

High-throughput Analysis of Locomotor Behavior in the Drosophila Island Assay

Published on: November 5, 2017

9.2K
Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration
08:41

Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration

Published on: December 27, 2024

2.0K
  • Correlation of ocular telangiectasia presence with disease severity and variants.

    • Main Results:

    • Ocular telangiectasias are a pathognomonic sign in Ataxia Telangiectasia.
    • The onset of ocular telangiectasias is typically observed after the age of six.
    • Milder Ataxia Telangiectasia variants may exhibit minimal or absent ocular telangiectasias.

    Conclusions:

    • Ocular telangiectasias are crucial for the clinical diagnosis of Ataxia Telangiectasia.
    • The absence or minimal presence of these signs may indicate milder disease forms.
    • Further research into the progeric aspects of telangiectasias is warranted.